Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-249,000
Closed -$884K 3617
2019
Q4
$884K Buy
249,000
+65,000
+35% +$1.09M ﹤0.01% 2344
2019
Q3
$429K Sell
184,000
-1,000
-0.5% -$14K ﹤0.01% 2758
2019
Q2
$43K Sell
185,000
-182,000
-50% -$2.1M ﹤0.01% 3515
2019
Q1
$111K Buy
+367,000
New +$3.95M ﹤0.01% 3370
2018
Q4
Sell
-102,000
Closed -$11K 3632
2018
Q3
$11K Buy
+102,000
New +$1.12M ﹤0.01% 3575
2018
Q1
Sell
-129,000
Closed -$14K 3527
2017
Q4
$14K Buy
+129,000
New +$1.36M ﹤0.01% 3362

Other funds holding KLAC

Raymond James & Associates's KLAC Position: Q3 2024 in Review

Raymond James & Associates increased its KLA (KLAC) stake by 5.5% in Q3 2024, buying an estimated $5.83M and bringing the position to 1,418,220 shares worth $110M. The position accounts for 0.07% of the portfolio, ranked #251.

Raymond James & Associates first reported a position in KLAC in Q2 2013 and has held it in 46 quarters since. The position peaked at $111M in Q2 2024. 1,545 funds tracked by Wall St. Rank hold KLAC as of Q3 2024.

  • Raymond James & Associates held 1,418,220 shares of KLA worth $110M as of Q3 2024.
  • Raymond James & Associates bought 74,350 KLA shares in Q3 2024, an estimated $5.83M.
  • KLA made up 0.07% of Raymond James & Associates's portfolio in Q3 2024, its #251 holding.
  • Raymond James & Associates first reported a position in KLA in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's KLA position peaked at $111M in Q2 2024.
  • 1,545 funds tracked by Wall St. Rank held KLA as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.